Chronic inflammatory states encompass conditions where sustained immune activation drives multisystem damage. Autoimmune conditions (RA, SLE, IBD) involve loss of immune tolerance with autoreactive T-cells and autoantibodies attacking self-tissue. Metabolic inflammation (metainflammation) in obesity involves adipocyte hypertrophy triggering macrophage infiltration and cytokine release (TNF-α, IL-6, MCP-1). These conditions share common downstream effects: endothelial dysfunction, insulin resistance, accelerated atherosclerosis, and increased thrombotic risk. The NP must manage both the primary inflammatory condition and its systemic cardiovascular and metabolic consequences.